Rajendra G. Mehta
Affiliations: | Illinois Institute of Technology, Chicago, IL, United States |
Area:
Biochemistry, Cell Biology, Biomedical EngineeringWebsite:
https://science.iit.edu/people/faculty/rajendra-mehtaGoogle:
"Rajendra Govindlal Mehta"Bio:
MEHTA, RAJENDRA GOVINDLAL, HORMONAL REGULATION OF LOBULO-ALVEOLAR DEVELOPMENT AND MACROMOLECULAR BIOSYNTHESIS OF THE ENTIRE MAMMARY GLAND IN ORGAN CULTURE.
(1974). ETD collection for University of Nebraska - Lincoln. AAI7516915.
http://digitalcommons.unl.edu/dissertations/AAI7516915
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Mihir R. Banerjee | grad student | 1974 | University of Nebraska - Lincoln (Cell Biology Tree) | |
| (Hormonal regulation of lobulo-alveolar development and macromolecular biosynthesis of the entire mammary gland in organ culture.) | ||||
| James Lamar Wittliff | post-doc | University of Louisville School of Medicine | ||
Children
Sign in to add trainee| Fatouma Alimirah | grad student | 2010 | Illinois Institute of Technology |
| Siva S. Dasa | grad student | 2011 | Illinois Institute of Technology |
| Akash Gupta | grad student | 2012 | Illinois Institute of Technology |
| Diana N. Vaz Saleiro | grad student | 2013 | Illinois Institute of Technology |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Singh S, Murillo G, Richner J, et al. (2022) A Broad-Based Characterization of a Cell-Penetrating, Single Domain Camelid Bi-Specific Antibody Monomer That Targets STAT3 and KRAS Dependent Cancers. International Journal of Molecular Sciences. 23 |
| Gupta A, Gupta G, Mehta RR, et al. (2020) A novel and cost-effective ex vivo orthotopic model for the study of human breast cancer in mouse mammary gland organ culture. Biology Open |
| Gupta A, Gupta G, Mehta RR, et al. (2020) A novel and cost-effective orthotopic model for the study of human breast cancer in mouse mammary gland organ culture. Biology Open |
| Singh S, Murillo G, Singh A, et al. (2019) Abstract 1544: Cell penetrating single domain antibody (sdAb) SBT-100 binds KRAS and inhibits growth of human cancers with KRAS activating mutations Cancer Research. 79: 1544-1544 |
| Kaur P, Robin, Mehta RG, et al. (2018) Progression of conventional hepatic cell culture models to bioengineered HepG2 cells for evaluation of herbal bioactivities. Biotechnology Letters |
| Singh S, Murillo G, Singh A, et al. (2018) Abstract 5436: Novel single-domain antibody (sdAb), SBT-100, localizes in the cytoplasm to inhibit IL-6 mediated P-STAT3 nuclear translocation in cancer cells Cancer Research. 78: 5436-5436 |
| Singh S, Murillo G, Singh A, et al. (2017) Effect of KRAS and P-STAT3 inhibition by SBT-100 on gemcitabine and pancreatic cancer growth in vivo. Journal of Clinical Oncology. 35 |
| Singh S, Murillo G, Singh A, et al. (2017) Single domain antibody (SBT-100) crosses the blood brain barrier (BBB) and inhibits human glioblastoma by selectively targeting KRAS and P-STAT3. Journal of Clinical Oncology. 35 |
| Singh S, Murillo G, Chen D, et al. (2017) Abstract P6-12-13: Single domain antibody (SBT-100) inhibits growth of human HER2+ and triple negative breast cancers (TNBC) in xenografts by binding STAT3 and P-STAT3 Cancer Research. 77 |
| Singh S, Murillo G, Rom A, et al. (2017) Abstract 4699: Single domain antibody (sdAb) localizes in cancer cells to inhibit signal transducer and activator of transcription 3 (STAT3) resulting in therapeutic inhibition of multiple cancers Cancer Research. 77: 4699-4699 |